Advanced search
Publication Cover
Emerging Microbes & Infections Volume 6, 2017 - Issue 1
Submit an article Journal homepage
1,181
Views
33
CrossRef citations to date
0
Altmetric
Letter To The Editor

Mutation in clpC1 encoding an ATP-dependent ATPase involved in protein degradation is associated with pyrazinamide resistance in Mycobacterium tuberculosis

Shuo ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public HealthJohns Hopkins University, Baltimore, MD21205, USA;Shandong Medicinal Biotechnology CentreShandong Academy of Medical Sciences, Jinan250062, China
,
Jiazhen ChenDepartment of Infectious Diseases, Huashan HospitalFudan University, Shanghai200040, China
,
Wanliang ShiDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public HealthJohns Hopkins University, Baltimore, MD21205, USA
,
Peng CuiDepartment of Infectious Diseases, Huashan HospitalFudan University, Shanghai200040, China
,
Jia ZhangDepartment of Infectious Diseases, Huashan HospitalFudan University, Shanghai200040, China
,
Sanghyun ChoCollege of Pharmacy, Institute for Tuberculosis ResearchUniversity of Illinois at Chicago, Chicago,IL60612, USA
,
Wenhong ZhangDepartment of Infectious Diseases, Huashan HospitalFudan University, Shanghai200040, ChinaCorrespondence[email protected] [email protected]
&
Ying ZhangDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public HealthJohns Hopkins University, Baltimore, MD21205, USA;Department of Infectious Diseases, Huashan HospitalFudan University, Shanghai200040, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1-2 | Received 04 Dec 2016, Accepted 09 Jan 2017, Published online: 15 Jan 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Emerging Microbes & Infections (2017) 6, e8; doi:10.1038/emi.2017.1; published online 15 February 2017

Acknowledgements

The work was supported in part by NIH Grant AI099512 and Major Project of the Twelfth Five-Year Plan (2013ZX10003008-003 and 2013ZX10003001-002).

Related Research Data

Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1
Source: Springer Science and Business Media LLC
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.
Source: Springer Science and Business Media LLC
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.
Source: Frontiers Media SA
Identification of Novel Mutations in LprG (rv1411c), rv0521, rv3630, rv0010c, ppsC, and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis.
Source: American Society for Microbiology
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Source: Informa UK Limited
Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance.
Source: American Society for Microbiology
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide.
Source: American Society for Microbiology
Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis
Source: American Society for Microbiology
New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.
Source: Frontiers Media SA
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo
Source: University of Illinois at Chicago
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
Source: Informa UK Limited
pncA Mutations as a Major Mechanism of Pyrazinamide Resistance in Mycobacterium tuberculosis: Spread of a Monoresistant Strain in Quebec, Canada
Source: American Society for Microbiology
Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2
Source: Elsevier Ltd.
Mechanisms of Pyrazinamide Action and Resistance
Source: American Society for Microbiology
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus
Source: Springer Science and Business Media LLC
Pyrazinamide Resistance Is Caused by Two Distinct Mechanisms: Prevention of Coenzyme A Depletion and Loss of Virulence Factor Synthesis
Source: American Chemical Society (ACS)

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.